Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Schiffman

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
Issues on clinical applications of cancer vaccinesM L Disis, K Schiffman
Clinical Lung Cancer|January 21, 2004
HER2/neu peptide-based vaccines, with GM-CSF as an adjuvant, in patients with advanced-stage HER2/neu-expressing cancersK Schiffman, M L Disis
Journal of Experimental Psychology|September 1, 1973
Concurrent measurement of autonomic and cognitive processes in a test of the traditional discriminative control procedure for Pavlovian electrodermal conditioningJ J Furedy, K Schiffman
Seminars in Oncology|January 5, 2002
Cancer vaccines targeting the HER2/neu oncogenic proteinM L Disis, K Schiffman
Journal of Experimental Psychology|November 1, 1971
Test of the propriety of the traditional discriminative control procedure in Pavlovian electrodermal and plethysmographic conditioningJ J Furedy, K Schiffman
Journal of Experimental Psychology|November 1, 1972
Failures of contingency and cognitive factors to affect long-interval differential Pavlovian autonomic conditioningK Schiffman, J J Furedy
Clinical Lung Cancer|January 22, 2004
Cancer vaccines for the treatment and prevention of non small-cell lung cancerM L Disis, H L West, K Schiffman
Journal of Orthopaedic Trauma|January 1, 1989
Dynamic condylar screw: a new device. A preliminary reportJ Schatzker, N Mahomed, K Schiffman, et al.
Blood|April 9, 1999
Immunization with recombinant human granulocyte-macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factorD G McNeel, K Schiffman, M L Disis
The Journal of Clinical Investigation|February 22, 2001
Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patientsK L Knutson, K Schiffman, M L Disis
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
Issues on clinical applications of cancer vaccinesM L Disis, K Schiffman
Clinical Lung Cancer|January 21, 2004
HER2/neu peptide-based vaccines, with GM-CSF as an adjuvant, in patients with advanced-stage HER2/neu-expressing cancersK Schiffman, M L Disis
Journal of Experimental Psychology|September 1, 1973
Concurrent measurement of autonomic and cognitive processes in a test of the traditional discriminative control procedure for Pavlovian electrodermal conditioningJ J Furedy, K Schiffman
Seminars in Oncology|January 5, 2002
Cancer vaccines targeting the HER2/neu oncogenic proteinM L Disis, K Schiffman
Journal of Experimental Psychology|November 1, 1971
Test of the propriety of the traditional discriminative control procedure in Pavlovian electrodermal and plethysmographic conditioningJ J Furedy, K Schiffman
Journal of Experimental Psychology|November 1, 1972
Failures of contingency and cognitive factors to affect long-interval differential Pavlovian autonomic conditioningK Schiffman, J J Furedy
Clinical Lung Cancer|January 22, 2004
Cancer vaccines for the treatment and prevention of non small-cell lung cancerM L Disis, H L West, K Schiffman
Journal of Orthopaedic Trauma|January 1, 1989
Dynamic condylar screw: a new device. A preliminary reportJ Schatzker, N Mahomed, K Schiffman, et al.
Blood|April 9, 1999
Immunization with recombinant human granulocyte-macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factorD G McNeel, K Schiffman, M L Disis
The Journal of Clinical Investigation|February 22, 2001
Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patientsK L Knutson, K Schiffman, M L Disis
Pageof 5